News Release
News Release
NEWS RELEASE
News Release
Notice of Business Transfer to Consolidated Subsidiary
Exercise of Option by MEDIPAL HOLDINGS CORPORATION
Notice of Completion of Subject Enrollment in Phase III Clinical Trial of Functional Peptide SR-0379
Notice Concerning the Completion of Subject Enrollment for the Phase I/IIa Clinical Study of Antibody-Inducing Peptide FPP003
Announcement of the start of joint research with Kumamoto University
Notice of Agreement between FunPep and EPS Innovative Medicine on Collaboration in China Business
Announcing the Start of Administration of Functional Peptide SR-0379 to Subjects in Phase III Clinical Trial
FunPep Signs Joint Research Agreement for a Next-generation Drug Formulation Technology for Antibody Inducing Peptides Using Microneedle Array Patch
Announcing the Start of Phase III Clinical Trials for Functional Peptide SR-0379
Submission of Clinical Trial Plan for a Phase III Clinical Trial of Functional Peptide SR-0379